The effects of transforming growth factor-β neutralization on postburn humoral immunity

Journal of Trauma - Injury, Infection and Critical Care

Volumn 57, Issue 3, 2004, Pages 529-536

  Ishikawa, Kazuo ^a   Nishimura, Tetsuro ^a   DeSerres, Suzan ^a   Meyer, Anthony A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Burn injury; Immunoglobulin synthesis; Transforming growth factor

Indexed keywords

CD19 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUTRALIZING ANTIBODY; NITRITE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIBODY FORMATION; BURNS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SPLEEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 4744348252     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000136306.53938.99     Document Type: Article

References (46)

1. Pruitt BA Jr. Infection and the burn patient. Br J Surg. 1990;77:1081-1082.
2. Cioffi WG. What's new in bums and metabolism. J Am Coll Surg. 2001;192:241-254.
3. Munster AM, Winchurch RA, Keane RM, et al. The "in vitro" skin test: a reliable and repeatable assay of immune competence in the surgical patients. Ann Surg. 1981;194:345-352.
4. Ninnemann JL, Fisher JC, Frank HA. Prolonged survival of human skin allografts following thermal injury. Transplantation. 1978;25:69-72.
5. Hultsman CS, Cairns BA, Yamamoto H, et al. The effect of bum injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitization. J Burn Care Rehabil. 1995;16:573-580.
6. Miller CL, Baker CC. Changes in lymphocyte activity after thermal injury: the role of suppressor cells. J Clin Invest. 1979;63:202-210.
7. Deitch EA, Xu D, Qi L. Different lymphocyte compartments respond differently to mitogenic stimulation after thermal injury. Ann Surg. 1990;211:72-77.
8. Kawakami M, Meyer AA, deSerres S. Immunoglobulin synthesis by cultured lymphocytes from spleen and mesenteric lymph nodes after thermal injury. J Burn Care Rehabil. 1991;12:474-480.
9. Tabata T, deSerres S, Meyer AA. Effects of burn injury on class-specific B cell population and immunoglobulin synthesis in mice. J Trauma. 1993;35:750-755.
10. Yamamoto H, Hayes YO, deSerres S, Chang J, Tabata T, Meyer AA. Burn injury induces a biphasic immunoglobulin M (IgM) response to bacterial antigen. J Trauma. 1995;39:279-285.
11. Yamamoto H, Siltharm S, deSerres S, Hultman CS, Meyer AA. Effect of cyclo-oxygenase inhibition on in vitro B-cell function after burn injury. J Trauma. 1996;41:612-621.
12. Nishimura T, Yamamoto H, deSerres S, Meyer AA. Transforming growth factor-β impairs post bum immunoglobulin production by limiting B-cell proliferation, but not cellular synthesis. J Trauma. 1999;46:881-885.
13. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol. 1996;8:199-205.
14. Spom MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol. 1992;119:1017-1021.
15. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol. 1986;137:3855-3860.
16. Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037-1050.
17. Nishimura T, Nishiura T, deSerres S, Nakagawa T, Brenner DA, Meyer AA. Impact of bum injury on hepatic TGF-beta1 expression and plasma TGF-beta1 levels. J Trauma. 2000;48:39-44.
18. Nishimura T, Nishiura T, deSerres S, Nakagawa T, Meyer AA. Transforming growth factor-beta1 and splenocyte apoptotic cell death after burn injuries. J Burn Care Rehabil. 2000;21:128-134.
19. Severinson E, Larsson E-L. Lymphocyte response to polyclonal B and T call activators. In: Weir DM, ed. Handbook of Experimental Immunology. 4th ed. Oxford, UK: Blackwell Scientific Publications; 1986:63.1-63.18.
20. Roberts AB, Frolik CA, Anzano MA, Sporn MB. Transforming growth factors from neoplastic and non-neoplastic tissues. Fed Proc. 1983;42:2621-2626.
21. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB. Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol. 1989;108:661-669.
22. Kehrl JH. Transforming growth factor-beta: an important mediator of immunoregulation. Int J Cell Cloning. 1991;9:438-450.
23. Amento EP, Beck LS. TGF-beta and wound healing. Ciba Found Symp. 1991;157:115-129.
24. Smeland EB, Blomhoff HK, Holte H, et al. Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res. 1987;171:213-222.
25. Arsura M, Wu M, Sonenshein GE. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity. 1996;5:31-40.
26. Stavnezer J. Regulation of antibody production and class switching by TGF-beta. J Immunol. 1995;155:1647-1651.
27. Bouchard C, Fridman WH, Sautes C. Mechanism of inhibition of lipopolysaccharide-stimulated mouse B-cell responses by transforming growth factor-beta 1. Immunol Lett. 1994;40:105-110.
28. Kehrl JH, Thevenin C, Rieckmann P, Fauci AS. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol. 1991;146:4016-4023.
29. Moulin V, Auger FA, O'Connor-McCourt M, Germain L. Fetal and postnatal sera differentially modulate human dermal fibroblast phenotypic and functional features in vitro. J Cell Physiol. 1997;171:1-10.
30. Hansbrough JF, Gadd MA. Temporal analysis of murine lymphocyte subpopulations by monoclonal antibodies and dual-color flow cytometry after burn and nonburn injury. Surgery. 1989;106:69-80.
31. Lee SH, Starkey PM, Gordon S. Quantitative analysis of total macrophage content in adult mouse tissues: immunochemical studies with monoclonal antibody F4/80. J Exp Med. 1985;161:475-489.
32. O'Riordain MG, Collins KH, Pilz M, et al. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch Surg. 1992;127:152-158.
33. Wu JZ, Ogle CK, Mao JX, et al. The increased potential for the production of inflammatory cytokines by Kupffer cells and splenic macrophages eight days after thermal injury. Inflammation. 1995;19:529-541.
34. Schwacha MG, Somers SD. Thermal injury-induced immunosuppression in mice: the role of macrophage-derived reactive nitrogen intermediates. J Leukoc Biol. 1998;63:51-58.
35. Schwacha MG, Chaudry IH. The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med. 2002;10:239-243.
36. Schwacha MG, Schneider CP, Bland KI, Chaudry IH. Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol. 2001;281:C1180-C1187.
37. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209-1220.
38. Varma TK, Lin CY, Toliver-Kinsky TE, Sherwood ER. Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors. Clin Diagn Lab Immunol. 2002;9:530-543.
39. Bellone G, Aste-Amezaga M, Trinchieri G, Rodeck U. Regulation of NK cell functions by TGF-beta 1. J Immunol. 1995;155:1066-1073.
40. Suzuki F, Pollard RB. Alterations of interferon production in a mouse model of thermal injury. J Immunol. 1982;129:1806-1810.
41. Durbin EA, Gregory MS, Messingham KA, Fontanilla CV, Duffner LA, Kovacs EJ. The role of interleukin 6 in interferon-gamma production in thermally injured mice. Cytokine. 2000;12:1669-1675.
42. Michael A, Hackett JJ, Bennett M, Kumar V, Yuan D. Regulation of B lymphocytes by natural killer cells: role of IFN-gamma. J Immunol. 1989;142:1095-1101.
43. Abed NS, Chace JH, Fleming AL, Cowdery JS. Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation. Cell Immunol. 1994;153:356-366.
44. Ben Jilani KE, Akarid K, Arnoult D, et al. Gamma-interferon induces apoptosis of the B lymphoma WEHI-279 cell line through a CD95/CD95L-independent mechanism. Eur Cytokine Netw. 2001;12:587-596.
45. Donjerkovic D, Scott DW. Activation-induced cell death in B lymphocytes. Cell Res. 2000;10:179-192.
46. Zuniga E, Motran C, Montes CL, et al. Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection. Clin Exp Immunol. 2000;119:507-515.